Recent News

• 06.11.2025 - Cabaletta Bio Announces Pricing of Public Offering of Securities
• 06.11.2025 - Cabaletta Bio Announces Pricing of Public Offering of Securities
• 06.11.2025 - Cabaletta Bio Announces Pricing of Public Offering of Securities
• 06.11.2025 - Cabaletta Bio Announces Proposed Public Offering of Securities
• 06.11.2025 - Cabaletta Bio Announces Proposed Public Offering of Securities
• 06.11.2025 - Cabaletta Bio Announces Proposed Public Offering of Securities
• 06.11.2025 - Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
• 06.11.2025 - Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

Recent Filings

• 06.10.2025 - 8-K Current report
• 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities